Hui Fu

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Hui Wang, Yuntao Zhang, Baoying Huang et al. · Cell · 2020 · 796 citations · Full text

Vaccination, Vaccine Development, Immunology +7

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

Shengli Xia, Yuntao Zhang, Yanxia Wang et al. · The Lancet Infectious Diseases · 2021 · 198 citations · Full text

A novel fiber-2-edited live attenuated vaccine candidate against the highly pathogenic serotype 4 fowl adenovirus

Quan Xie, Shiya Cao, Wei Zhang et al. · Veterinary Research · 2021 · 37 citations · Full text

Domain in Fiber-2 interacted with KPNA3/4 significantly affects the replication and pathogenicity of the highly pathogenic FAdV-4

Quan Xie, Weikang Wang, Luyuan Li et al. · Virulence · 2021 · 32 citations · Full text

FAdV-4 without <i>Fiber-2</i> Is a Highly Attenuated and Protective Vaccine Candidate

Quan Xie, Weikang Wang, Qiuqi Kan et al. · Microbiology Spectrum · 2022 · 29 citations · Full text